Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
All Or Nothing: Paratek Withdraws EU Filing For Nuzyra
Drug Is Approved In US And Was In Final Stages Of EMA Review
Oct 17 2019
•
By
Vibha Sharma
Antibiotic Nuzyra was in final stages of review before EMA • Source: Shutterstock
More from Europe
More from Geography